Courier Capital LLC Astrazeneca PLC Transaction History

Courier Capital LLC

$1.44 Billion
Q3 2024

A detailed history of Courier Capital LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Courier Capital LLC holds 9,317 shares of AZN stock, worth $600,387. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,317

Previous 9,717 4.12%

Holding current value

$600,387

Previous $757,000 4.23%

% of portfolio

0.05%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$76.67 - $87.62 $30,668 - $35,048	-400 Reduced 4.12%	9,317 $725,000
Q1 2023 May 18, 2023	SELL	$63.15 - $71.6 $18,945 - $21,480	-300 Reduced 2.99%	9,717 $674,000
Q3 2021 Oct 14, 2021	BUY	$55.56 - $60.79 $4,444 - $4,863	80 Added 0.81%	10,017 $602,000
Q2 2021 Jul 12, 2021	SELL	$48.42 - $60.18 $48,420 - $60,180	-1,000 Reduced 9.14%	9,937 $595,000
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $4,852 - $5,802	100 Added 0.92%	10,937 $547,000
Q3 2020 Nov 09, 2020	BUY	$53.07 - $61.1 $47,763 - $54,990	900 Added 9.06%	10,837 $602,000
Q2 2020 Jul 06, 2020	SELL	$43.1 - $55.31 $11,421 - $14,657	-265 Reduced 2.6%	9,937 $535,000
Q1 2020 Apr 22, 2020	BUY	$37.79 - $51.33 $10,014 - $13,602	265 Added 2.67%	10,202 $511,000
Q2 2019 Jul 16, 2019	SELL	$37.28 - $41.68 $2,982 - $3,334	-80 Reduced 0.8%	9,937 $410,000
Q3 2018 Oct 12, 2018	BUY	$34.76 - $39.72 $2,780 - $3,177	80 Added 0.81%	10,017 $396,000
Q3 2017 Nov 03, 2017	BUY	$28.96 - $34.0 $32,232 - $37,842	1,113 Added 12.61%	9,937 $337,000
Q2 2017 Aug 10, 2017	BUY	N/A	8,824	8,824 $301,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Courier Capital LLC with notifications on news.

Account

Courier Capital LLC Astrazeneca PLC Transaction History